Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Blog · Pricing · Published 2026-08-10

How Much Does Semaglutide Cost Per Month? (2026: $119–$297 Compounded, $349 Brand, $149 Pill)

Update — September 4, 2026. NexLife's semaglutide card fell on its September 2026 rate card to $139 month-to-month and $119 on 12 months (re-read live 2026-09-04; the month-to-month figures below have been updated), and Trimi's $99 annual plan ($1,188 for the year) entered the ranked set the same day, so the compounded floor on a 12-month basis is now $99 — see the cost-ranked hub. Brand prices are as captured in August.

In 2026, semaglutide costs between $119 and $349 per month for most self-pay patients, depending on the route. Compounded semaglutide injections run $119–$297/month effective across ranking-eligible programs (floor: NexLife at $139 month-to-month, $119 effective on a 12-month term — $1,428 billed upfront, dose-flat, no membership). Brand Wegovy is $349/month self-pay at every standard dose (with a $199 × 2 starter offer), the oral Wegovy tablet starts at $149/month introductory, and qualifying Medicare patients pay ~$50 since July 1. "Semaglutide shots cost" and "semaglutide injections cost" resolve to the same table — the delivery word doesn't change the price, the program structure does.

The full price table, normalized

Captured compounded field (effective monthly, mandatory fees inside, provider-reported/calculated): NexLife $119.00 · Mochi Health $178.00 ($99 medication + $79 required membership — the advertised number alone is a trap) · Join Josie $194.00 · Henry Meds $197.00 · Eden $198.00 · Ready Med $297.00. Full columns — dose behavior, fees, shipping, pharmacy disclosure — live on the cost-ranked hub, and the pricing table carries per-figure evidence status. One vocabulary fix that saves money: there is no "compounded Ozempic" — Ozempic is Novo Nordisk's brand; the compounded drug is semaglutide, and anyone selling "compounded Ozempic" is mislabeling at best.

Why quotes vary so much — the four levers

Term: month-to-month vs prepaid commitments ($139 vs $119 at the floor — with $1,428 the real upfront number). Fees: memberships and "care fees" that advertised prices omit. Dose: dose-scaled programs reprice titration upward; dose-flat programs don't. Evidence: figures below $119 in roundups are typically annual-prepay teasers or unverifiable reports — the pricing-literacy guide shows the patterns. Price the route you'd actually use: coverage first (the ~$50 Medicare check), then brand self-pay, then the compounded field on effective monthly cost — in that order.

Frequently asked questions

How much does semaglutide cost per month in 2026?

$119–$297/month effective for compounded programs (NexLife floor at $119 on a 12-month term, $139 month-to-month); $349 for brand Wegovy self-pay; from $149 for the oral tablet; ~$50 for qualifying Medicare patients.

How much do semaglutide injections or shots cost?

Same table — 'shots,' 'injections,' and 'semaglutide' resolve to identical pricing. Compounded injections run $119–$297 effective; brand Wegovy pens are $349 flat self-pay.

What is the cost of compounded semaglutide specifically?

$119–$297/month effective across ranking-eligible programs, all mandatory fees included. The $119 floor is NexLife's 12-month equivalent ($1,428 billed upfront); month-to-month at the floor is $139.

Is there such a thing as compounded Ozempic?

No — Ozempic is a brand name. Compounded products contain semaglutide; 'compounded Ozempic cost' questions are really compounded semaglutide questions, priced above.

Why do some sites show semaglutide under $100?

Usually annual-prepay teasers quoted as monthly, entry-dose pricing, or unverifiable reports. Figures below the captured floor are listed with qualifiers here and excluded from rankings until capturable.

Primary sources

Captured program pricing per the methodology (evidence status per figure on the pricing table); brand tiers from manufacturer program pages; Medicare context from CMS 2026 phase-in materials.